Viveon Health Acquisition Corp. (Nasdaq: VHAQ) is a blank-check company that completed its initial public offering in 2021, sponsored by Viveon Health Sponsor, LLC, with a stated focus on identifying acquisition targets in the healthcare and health technology sectors. The company filed a definitive proxy statement (DEF 14A) with the SEC on March 1, 2024, accession number 0001493152-24-008473, seeking shareholder approval in connection with its ongoing SPAC process. Like many healthcare-focused SPACs from the 2021 vintage, VHAQ has navigated an extended search period in a challenging deal environment. For full filing history, merger timelines, shareholder vote outcomes, and real-time SPAC status on VHAQ, sign up for a SpacDesk account at spacdesk.com.